Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Up Following Strong Earnings

Posted by Francis Steltz on Aug 14th, 2026

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) gapped up before the market opened on Friday after the company announced better than expected quarterly earnings. The stock had previously closed at $11.29, but opened at $11.91. Aveanna Healthcare shares last traded at $11.8650, with a volume of 819,480 shares changing hands.

The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.03. The company had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%.

More Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

Positive Sentiment: Strong Q2 results: Second-quarter revenue rose 13.7% year over year to $670.5 million, surpassing the $638.6 million analyst estimate. Adjusted earnings of $0.22 per share also exceeded consensus expectations, while net income increased to $40.3 million from $27.0 million a year earlier. Aveanna Healthcare second-quarter results and revised guidance
Positive Sentiment: Guidance raised: Aveanna increased 2026 revenue guidance to more than $2.68 billion, up from $2.63 billion to $2.65 billion, and lifted adjusted EBITDA guidance to more than $365 million from $338 million to $342 million. The upgraded outlook signals stronger expected operating momentum. Aveanna hits 52-week high after Q2 beat and guidance hike
Positive Sentiment: Analyst becomes more bullish: BMO Capital Markets raised its price target from $10 to $14 and upgraded the stock to “outperform,” implying additional upside from the referenced $11.29 level. Benzinga analyst price-target report
Neutral Sentiment: Business momentum remains concentrated: Private Duty Services generate approximately 83% of revenue. Analysts highlighted strong growth and attractive forward valuation, but investors will be watching whether the company can sustain that growth across its broader home-care platform.
Negative Sentiment: Margin pressure is a risk: Gross margins declined across all business segments in the quarter. Continued revenue growth has offset that pressure so far, but further margin deterioration could limit earnings expansion and temper the stock’s rally.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. BMO Capital Markets increased their price target on Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research note on Friday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Barclays lifted their target price on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. Truist Financial boosted their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Finally, Raymond James Financial reaffirmed a “strong-buy” rating and set a $15.00 price target on shares of Aveanna Healthcare in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $11.44.

Read Our Latest Research Report on Aveanna Healthcare

Insider Transactions at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 5,842,240 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total value of $36,455,577.60. Following the transaction, the insider owned 13,450,547 shares in the company, valued at approximately $83,931,413.28. This represents a 30.28% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total value of $43,680,000.00. Following the sale, the insider owned 252,899 shares of the company’s stock, valued at approximately $1,578,089.76. This represents a 96.51% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 31,305,664 shares of company stock valued at $215,555,910 in the last 90 days. Corporate insiders own 5.30% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd grew its holdings in shares of Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after buying an additional 2,400 shares during the last quarter. Quantbot Technologies LP acquired a new stake in shares of Aveanna Healthcare in the 2nd quarter worth about $43,000. Summit Securities Group LLC bought a new position in Aveanna Healthcare in the 1st quarter valued at about $53,000. Oxford Asset Management LLP bought a new position in Aveanna Healthcare in the 2nd quarter valued at about $64,000. Finally, C M Bidwell & Associates Ltd. acquired a new position in Aveanna Healthcare during the 2nd quarter valued at about $69,000. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Price Performance

The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35. The business has a fifty day simple moving average of $8.86 and a 200 day simple moving average of $7.73. The stock has a market capitalization of $2.59 billion, a P/E ratio of 10.12, a price-to-earnings-growth ratio of 0.90 and a beta of 1.90.

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.